ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemostatic Powders and Hemostatic Agents Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33I12151
Home | Market Reports | Health| Medical Devices & Equipment
Global Hemostatic Powders and Hemostatic Agents Market Research Report 2022
BUY CHAPTERS

Global Hemostatic Powders and Hemostatic Agents Market Research Report 2025

Code: QYRE-Auto-33I12151
Report
March 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BD
Medline Industries
Baxter
Pfizer Inc
Integra Life Sciences
Medtronic Inc
CryoLife
CSL Behring
Ethicon Inc
B. Braun Melsungen
Gelita Medical
Smith & Nephew
Teleflex
Zimmer Biomet
Mckesson
Novartis
Anika Therapeutics
Advanced Medical Solutions

Hemostatic Powders and Hemostatic Agents Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Hemostatic Powders and Hemostatic Agents Market

Hemostatic Powders and Hemostatic Agents Market

The global market for Hemostatic Powders and Hemostatic Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Hemostatic powders and hemostatic agents are medical products used to control bleeding or promote hemostasis (the process of stopping bleeding) in various clinical settings. These products are designed to aid in the management of bleeding in situations where conventional methods such as pressure, sutures, or cauterization may be insufficient or impractical.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Powders and Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Powders and Hemostatic Agents.
The Hemostatic Powders and Hemostatic Agents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemostatic Powders and Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Powders and Hemostatic Agents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hemostatic Powders and Hemostatic Agents Market Report

Report Metric Details
Report Name Hemostatic Powders and Hemostatic Agents Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
  • Home
  • Clinic
  • Hospital
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, Medline Industries, Baxter, Pfizer, Zimmer Biomet, McKesson, Integra Life Sciences, Medtronic, CryoLife, CSL Behring, Ethicon, B Braun Melsungen, Gelita Medical, Smith & Nephew, Teleflex, Novartis, Anika Therapeutics, Advanced Medical Solutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hemostatic Powders and Hemostatic Agents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hemostatic Powders and Hemostatic Agents Market report?

Ans: The main players in the Hemostatic Powders and Hemostatic Agents Market are BD, Medline Industries, Baxter, Pfizer, Zimmer Biomet, McKesson, Integra Life Sciences, Medtronic, CryoLife, CSL Behring, Ethicon, B Braun Melsungen, Gelita Medical, Smith & Nephew, Teleflex, Novartis, Anika Therapeutics, Advanced Medical Solutions

What are the Application segmentation covered in the Hemostatic Powders and Hemostatic Agents Market report?

Ans: The Applications covered in the Hemostatic Powders and Hemostatic Agents Market report are Home, Clinic, Hospital

What are the Type segmentation covered in the Hemostatic Powders and Hemostatic Agents Market report?

Ans: The Types covered in the Hemostatic Powders and Hemostatic Agents Market report are Microfibrous Collagen, Chitosan

Recommended Reports

Hemostatic Products

Hemostatic Sponge & Dressings

Hemostatic Powders & Adjuncts

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Microfibrous Collagen
1.2.3 Chitosan
1.3 Market by Application
1.3.1 Global Hemostatic Powders and Hemostatic Agents Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Home
1.3.3 Clinic
1.3.4 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemostatic Powders and Hemostatic Agents Market Perspective (2020-2031)
2.2 Global Hemostatic Powders and Hemostatic Agents Growth Trends by Region
2.2.1 Global Hemostatic Powders and Hemostatic Agents Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hemostatic Powders and Hemostatic Agents Historic Market Size by Region (2020-2025)
2.2.3 Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Region (2026-2031)
2.3 Hemostatic Powders and Hemostatic Agents Market Dynamics
2.3.1 Hemostatic Powders and Hemostatic Agents Industry Trends
2.3.2 Hemostatic Powders and Hemostatic Agents Market Drivers
2.3.3 Hemostatic Powders and Hemostatic Agents Market Challenges
2.3.4 Hemostatic Powders and Hemostatic Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemostatic Powders and Hemostatic Agents Players by Revenue
3.1.1 Global Top Hemostatic Powders and Hemostatic Agents Players by Revenue (2020-2025)
3.1.2 Global Hemostatic Powders and Hemostatic Agents Revenue Market Share by Players (2020-2025)
3.2 Global Hemostatic Powders and Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hemostatic Powders and Hemostatic Agents Revenue
3.4 Global Hemostatic Powders and Hemostatic Agents Market Concentration Ratio
3.4.1 Global Hemostatic Powders and Hemostatic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemostatic Powders and Hemostatic Agents Revenue in 2024
3.5 Global Key Players of Hemostatic Powders and Hemostatic Agents Head office and Area Served
3.6 Global Key Players of Hemostatic Powders and Hemostatic Agents, Product and Application
3.7 Global Key Players of Hemostatic Powders and Hemostatic Agents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemostatic Powders and Hemostatic Agents Breakdown Data by Type
4.1 Global Hemostatic Powders and Hemostatic Agents Historic Market Size by Type (2020-2025)
4.2 Global Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Type (2026-2031)
5 Hemostatic Powders and Hemostatic Agents Breakdown Data by Application
5.1 Global Hemostatic Powders and Hemostatic Agents Historic Market Size by Application (2020-2025)
5.2 Global Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hemostatic Powders and Hemostatic Agents Market Size (2020-2031)
6.2 North America Hemostatic Powders and Hemostatic Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hemostatic Powders and Hemostatic Agents Market Size by Country (2020-2025)
6.4 North America Hemostatic Powders and Hemostatic Agents Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemostatic Powders and Hemostatic Agents Market Size (2020-2031)
7.2 Europe Hemostatic Powders and Hemostatic Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hemostatic Powders and Hemostatic Agents Market Size by Country (2020-2025)
7.4 Europe Hemostatic Powders and Hemostatic Agents Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size (2020-2031)
8.2 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region (2020-2025)
8.4 Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemostatic Powders and Hemostatic Agents Market Size (2020-2031)
9.2 Latin America Hemostatic Powders and Hemostatic Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Country (2020-2025)
9.4 Latin America Hemostatic Powders and Hemostatic Agents Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size (2020-2031)
10.2 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country (2020-2025)
10.4 Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Hemostatic Powders and Hemostatic Agents Introduction
11.1.4 BD Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.1.5 BD Recent Development
11.2 Medline Industries
11.2.1 Medline Industries Company Details
11.2.2 Medline Industries Business Overview
11.2.3 Medline Industries Hemostatic Powders and Hemostatic Agents Introduction
11.2.4 Medline Industries Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.2.5 Medline Industries Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Hemostatic Powders and Hemostatic Agents Introduction
11.3.4 Baxter Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.3.5 Baxter Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Hemostatic Powders and Hemostatic Agents Introduction
11.4.4 Pfizer Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Zimmer Biomet
11.5.1 Zimmer Biomet Company Details
11.5.2 Zimmer Biomet Business Overview
11.5.3 Zimmer Biomet Hemostatic Powders and Hemostatic Agents Introduction
11.5.4 Zimmer Biomet Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.5.5 Zimmer Biomet Recent Development
11.6 McKesson
11.6.1 McKesson Company Details
11.6.2 McKesson Business Overview
11.6.3 McKesson Hemostatic Powders and Hemostatic Agents Introduction
11.6.4 McKesson Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.6.5 McKesson Recent Development
11.7 Integra Life Sciences
11.7.1 Integra Life Sciences Company Details
11.7.2 Integra Life Sciences Business Overview
11.7.3 Integra Life Sciences Hemostatic Powders and Hemostatic Agents Introduction
11.7.4 Integra Life Sciences Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.7.5 Integra Life Sciences Recent Development
11.8 Medtronic
11.8.1 Medtronic Company Details
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Hemostatic Powders and Hemostatic Agents Introduction
11.8.4 Medtronic Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.8.5 Medtronic Recent Development
11.9 CryoLife
11.9.1 CryoLife Company Details
11.9.2 CryoLife Business Overview
11.9.3 CryoLife Hemostatic Powders and Hemostatic Agents Introduction
11.9.4 CryoLife Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.9.5 CryoLife Recent Development
11.10 CSL Behring
11.10.1 CSL Behring Company Details
11.10.2 CSL Behring Business Overview
11.10.3 CSL Behring Hemostatic Powders and Hemostatic Agents Introduction
11.10.4 CSL Behring Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.10.5 CSL Behring Recent Development
11.11 Ethicon
11.11.1 Ethicon Company Details
11.11.2 Ethicon Business Overview
11.11.3 Ethicon Hemostatic Powders and Hemostatic Agents Introduction
11.11.4 Ethicon Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.11.5 Ethicon Recent Development
11.12 B Braun Melsungen
11.12.1 B Braun Melsungen Company Details
11.12.2 B Braun Melsungen Business Overview
11.12.3 B Braun Melsungen Hemostatic Powders and Hemostatic Agents Introduction
11.12.4 B Braun Melsungen Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.12.5 B Braun Melsungen Recent Development
11.13 Gelita Medical
11.13.1 Gelita Medical Company Details
11.13.2 Gelita Medical Business Overview
11.13.3 Gelita Medical Hemostatic Powders and Hemostatic Agents Introduction
11.13.4 Gelita Medical Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.13.5 Gelita Medical Recent Development
11.14 Smith & Nephew
11.14.1 Smith & Nephew Company Details
11.14.2 Smith & Nephew Business Overview
11.14.3 Smith & Nephew Hemostatic Powders and Hemostatic Agents Introduction
11.14.4 Smith & Nephew Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.14.5 Smith & Nephew Recent Development
11.15 Teleflex
11.15.1 Teleflex Company Details
11.15.2 Teleflex Business Overview
11.15.3 Teleflex Hemostatic Powders and Hemostatic Agents Introduction
11.15.4 Teleflex Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.15.5 Teleflex Recent Development
11.16 Novartis
11.16.1 Novartis Company Details
11.16.2 Novartis Business Overview
11.16.3 Novartis Hemostatic Powders and Hemostatic Agents Introduction
11.16.4 Novartis Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.16.5 Novartis Recent Development
11.17 Anika Therapeutics
11.17.1 Anika Therapeutics Company Details
11.17.2 Anika Therapeutics Business Overview
11.17.3 Anika Therapeutics Hemostatic Powders and Hemostatic Agents Introduction
11.17.4 Anika Therapeutics Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.17.5 Anika Therapeutics Recent Development
11.18 Advanced Medical Solutions
11.18.1 Advanced Medical Solutions Company Details
11.18.2 Advanced Medical Solutions Business Overview
11.18.3 Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Introduction
11.18.4 Advanced Medical Solutions Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
11.18.5 Advanced Medical Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
BD
Medline Industries
Baxter
Pfizer Inc
Integra Life Sciences
Medtronic Inc
CryoLife
CSL Behring
Ethicon Inc
B. Braun Melsungen
Gelita Medical
Smith & Nephew
Teleflex
Zimmer Biomet
Mckesson
Novartis
Anika Therapeutics
Advanced Medical Solutions
List of Tables
 Table 1. Global Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Microfibrous Collagen
 Table 3. Key Players of Chitosan
 Table 4. Global Hemostatic Powders and Hemostatic Agents Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Hemostatic Powders and Hemostatic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Hemostatic Powders and Hemostatic Agents Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Hemostatic Powders and Hemostatic Agents Market Share by Region (2020-2025)
 Table 8. Global Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Hemostatic Powders and Hemostatic Agents Market Share by Region (2026-2031)
 Table 10. Hemostatic Powders and Hemostatic Agents Market Trends
 Table 11. Hemostatic Powders and Hemostatic Agents Market Drivers
 Table 12. Hemostatic Powders and Hemostatic Agents Market Challenges
 Table 13. Hemostatic Powders and Hemostatic Agents Market Restraints
 Table 14. Global Hemostatic Powders and Hemostatic Agents Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Hemostatic Powders and Hemostatic Agents Market Share by Players (2020-2025)
 Table 16. Global Top Hemostatic Powders and Hemostatic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Powders and Hemostatic Agents as of 2024)
 Table 17. Ranking of Global Top Hemostatic Powders and Hemostatic Agents Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Hemostatic Powders and Hemostatic Agents Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Hemostatic Powders and Hemostatic Agents, Headquarters and Area Served
 Table 20. Global Key Players of Hemostatic Powders and Hemostatic Agents, Product and Application
 Table 21. Global Key Players of Hemostatic Powders and Hemostatic Agents, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Hemostatic Powders and Hemostatic Agents Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Hemostatic Powders and Hemostatic Agents Revenue Market Share by Type (2020-2025)
 Table 25. Global Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Hemostatic Powders and Hemostatic Agents Revenue Market Share by Type (2026-2031)
 Table 27. Global Hemostatic Powders and Hemostatic Agents Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Hemostatic Powders and Hemostatic Agents Revenue Market Share by Application (2020-2025)
 Table 29. Global Hemostatic Powders and Hemostatic Agents Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Hemostatic Powders and Hemostatic Agents Revenue Market Share by Application (2026-2031)
 Table 31. North America Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Hemostatic Powders and Hemostatic Agents Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Hemostatic Powders and Hemostatic Agents Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Hemostatic Powders and Hemostatic Agents Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Hemostatic Powders and Hemostatic Agents Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Hemostatic Powders and Hemostatic Agents Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Hemostatic Powders and Hemostatic Agents Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size by Country (2026-2031) & (US$ Million)
 Table 46. BD Company Details
 Table 47. BD Business Overview
 Table 48. BD Hemostatic Powders and Hemostatic Agents Product
 Table 49. BD Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 50. BD Recent Development
 Table 51. Medline Industries Company Details
 Table 52. Medline Industries Business Overview
 Table 53. Medline Industries Hemostatic Powders and Hemostatic Agents Product
 Table 54. Medline Industries Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 55. Medline Industries Recent Development
 Table 56. Baxter Company Details
 Table 57. Baxter Business Overview
 Table 58. Baxter Hemostatic Powders and Hemostatic Agents Product
 Table 59. Baxter Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 60. Baxter Recent Development
 Table 61. Pfizer Company Details
 Table 62. Pfizer Business Overview
 Table 63. Pfizer Hemostatic Powders and Hemostatic Agents Product
 Table 64. Pfizer Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 65. Pfizer Recent Development
 Table 66. Zimmer Biomet Company Details
 Table 67. Zimmer Biomet Business Overview
 Table 68. Zimmer Biomet Hemostatic Powders and Hemostatic Agents Product
 Table 69. Zimmer Biomet Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 70. Zimmer Biomet Recent Development
 Table 71. McKesson Company Details
 Table 72. McKesson Business Overview
 Table 73. McKesson Hemostatic Powders and Hemostatic Agents Product
 Table 74. McKesson Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 75. McKesson Recent Development
 Table 76. Integra Life Sciences Company Details
 Table 77. Integra Life Sciences Business Overview
 Table 78. Integra Life Sciences Hemostatic Powders and Hemostatic Agents Product
 Table 79. Integra Life Sciences Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 80. Integra Life Sciences Recent Development
 Table 81. Medtronic Company Details
 Table 82. Medtronic Business Overview
 Table 83. Medtronic Hemostatic Powders and Hemostatic Agents Product
 Table 84. Medtronic Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 85. Medtronic Recent Development
 Table 86. CryoLife Company Details
 Table 87. CryoLife Business Overview
 Table 88. CryoLife Hemostatic Powders and Hemostatic Agents Product
 Table 89. CryoLife Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 90. CryoLife Recent Development
 Table 91. CSL Behring Company Details
 Table 92. CSL Behring Business Overview
 Table 93. CSL Behring Hemostatic Powders and Hemostatic Agents Product
 Table 94. CSL Behring Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 95. CSL Behring Recent Development
 Table 96. Ethicon Company Details
 Table 97. Ethicon Business Overview
 Table 98. Ethicon Hemostatic Powders and Hemostatic Agents Product
 Table 99. Ethicon Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 100. Ethicon Recent Development
 Table 101. B Braun Melsungen Company Details
 Table 102. B Braun Melsungen Business Overview
 Table 103. B Braun Melsungen Hemostatic Powders and Hemostatic Agents Product
 Table 104. B Braun Melsungen Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 105. B Braun Melsungen Recent Development
 Table 106. Gelita Medical Company Details
 Table 107. Gelita Medical Business Overview
 Table 108. Gelita Medical Hemostatic Powders and Hemostatic Agents Product
 Table 109. Gelita Medical Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 110. Gelita Medical Recent Development
 Table 111. Smith & Nephew Company Details
 Table 112. Smith & Nephew Business Overview
 Table 113. Smith & Nephew Hemostatic Powders and Hemostatic Agents Product
 Table 114. Smith & Nephew Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 115. Smith & Nephew Recent Development
 Table 116. Teleflex Company Details
 Table 117. Teleflex Business Overview
 Table 118. Teleflex Hemostatic Powders and Hemostatic Agents Product
 Table 119. Teleflex Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 120. Teleflex Recent Development
 Table 121. Novartis Company Details
 Table 122. Novartis Business Overview
 Table 123. Novartis Hemostatic Powders and Hemostatic Agents Product
 Table 124. Novartis Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 125. Novartis Recent Development
 Table 126. Anika Therapeutics Company Details
 Table 127. Anika Therapeutics Business Overview
 Table 128. Anika Therapeutics Hemostatic Powders and Hemostatic Agents Product
 Table 129. Anika Therapeutics Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 130. Anika Therapeutics Recent Development
 Table 131. Advanced Medical Solutions Company Details
 Table 132. Advanced Medical Solutions Business Overview
 Table 133. Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Product
 Table 134. Advanced Medical Solutions Revenue in Hemostatic Powders and Hemostatic Agents Business (2020-2025) & (US$ Million)
 Table 135. Advanced Medical Solutions Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Hemostatic Powders and Hemostatic Agents Picture
 Figure 2. Global Hemostatic Powders and Hemostatic Agents Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hemostatic Powders and Hemostatic Agents Market Share by Type: 2024 VS 2031
 Figure 4. Microfibrous Collagen Features
 Figure 5. Chitosan Features
 Figure 6. Global Hemostatic Powders and Hemostatic Agents Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hemostatic Powders and Hemostatic Agents Market Share by Application: 2024 VS 2031
 Figure 8. Home Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Hospital Case Studies
 Figure 11. Hemostatic Powders and Hemostatic Agents Report Years Considered
 Figure 12. Global Hemostatic Powders and Hemostatic Agents Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Hemostatic Powders and Hemostatic Agents Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Hemostatic Powders and Hemostatic Agents Market Share by Region: 2024 VS 2031
 Figure 15. Global Hemostatic Powders and Hemostatic Agents Market Share by Players in 2024
 Figure 16. Global Top Hemostatic Powders and Hemostatic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Powders and Hemostatic Agents as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Hemostatic Powders and Hemostatic Agents Revenue in 2024
 Figure 18. North America Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Hemostatic Powders and Hemostatic Agents Market Share by Country (2020-2031)
 Figure 20. United States Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Hemostatic Powders and Hemostatic Agents Market Share by Country (2020-2031)
 Figure 24. Germany Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Hemostatic Powders and Hemostatic Agents Market Share by Region (2020-2031)
 Figure 32. China Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Hemostatic Powders and Hemostatic Agents Market Share by Country (2020-2031)
 Figure 40. Mexico Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Hemostatic Powders and Hemostatic Agents Market Share by Country (2020-2031)
 Figure 44. Turkey Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Hemostatic Powders and Hemostatic Agents Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. BD Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 48. Medline Industries Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 49. Baxter Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 50. Pfizer Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 51. Zimmer Biomet Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 52. McKesson Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 53. Integra Life Sciences Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 54. Medtronic Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 55. CryoLife Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 56. CSL Behring Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 57. Ethicon Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 58. B Braun Melsungen Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 59. Gelita Medical Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 60. Smith & Nephew Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 61. Teleflex Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 62. Novartis Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 63. Anika Therapeutics Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 64. Advanced Medical Solutions Revenue Growth Rate in Hemostatic Powders and Hemostatic Agents Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Powder Hemostatic Agent Market Insights Forecast to 2030
Medical Hemostatic Powders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostatic Agents Market Research Report 2025
Global Hemostatic Agents and Tissue Sealants Market Research Report 2025
Hemostat Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Surgery Hemostat Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Research Report 2025
Wound Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Hemostatic Powder Spray Market Research Report 2024
Global Medical Absorbable Hemostatic Powder Market Insights Forecast to 2030
Active Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polysaccharide Hemostat Powder Market Research Report 2024
Chitosan Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Absorbable Surgical Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Endoscopic Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Absorbable Hemostat Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Absorbable Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Polysaccharide Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polysaccharide Hemostatic Powder Market Research Report 2025

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions